What is the BEAM stock price prediction for next 2 weeks?

According to our price prediction algorithm,Beam Therapeutics Inc. (BEAM) price will be around $39.29 in the next 2 weeks. This means it will increase by 28.03779732811991 from the last closing price. This prediction may vary from other time period filters for BEAM stock.

What can be the highest Possible price of BEAM stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BEAM can achieve the highest price of $40.66 which is 32.487707027456366 higher than last closing price. This prediction may vary from other time period filters for BEAM stock.

What can be the lowest Possible price of BEAM stock in next 2 weeks?

As per the forecast and algorithmic analysis, BEAM stock price can be as low as $37.90 which is 23.486290649159066 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for BEAM stock.

Will BEAM stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that BEAM stock will gain28.03779732811991 in the next 2 weeks. This prediction may vary from other time period filters for BEAM stock.

What is BEAM stock last closing price?

Last closing price of BEAM stock was $31.69.

What is BEAM stock price prediction?

BEAM stock price prediction means predicting the future closing prices of BEAM stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BEAM stock in a certain time period.

How we predict BEAM stock future prices?

If you are searching for BEAM stock forecast, analysis or price prediction, then you might be wondering what Beam Therapeutics Inc. (BEAM) will do in the future. Our BEAM price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BEAM price prediction will likely answer most of your questions.

How frequent we update BEAM stock predictions?

We are updating the forecasts for the BEAM stock on daily basis.

Is using ML forecasting for BEAM stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BEAM stock same for all the time periods?

No, the prediction for BEAM stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Beam Therapeutics Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$31.6924.57%Since 2 Weeks

Predicted Price$39.2928.04%For 2 Weeks

Upper Predicted Price$40.6632.49%For 2 Weeks

Lower Predicted Price$37.9023.49%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BEAM will rise by +28.04% over the next 2 Weeks and hit $39.29 by Tuesday, May 5, 2026. In that time frame, BEAM's share price is expected to range between $37.90 and $40.66.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 6, 2026	36.64	37.97	39.27
May 5, 2026	36.29	37.59	38.87
May 4, 2026	36.21	37.34	38.51
May 1, 2026	34.45	35.51	36.63
Apr 30, 2026	34.35	35.38	36.39
Apr 29, 2026	33.72	34.68	35.70
Apr 28, 2026	33.34	34.30	35.25
Apr 27, 2026	33.06	34.05	34.95
Apr 24, 2026	31.31	32.22	33.13
Apr 23, 2026	31.23	32.08	32.99

BEAM shares rose +3.26% in Wednesday, April 22, 2026's trading session, rising from a previous close of $30.69 to move at $31.69. The stock demonstrated notable intraday movement (see BEAM's key stats for a full breakdown), fluctuating between $31.01 and $31.99, a +3.17% trading range. While recent weeks have seen some volatility, BEAM has managed to secure a +24.57% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.66M shares changing hands, 83.25K fewer than the previous session. This amounted to $52.73M in total market activity.

Will BEAM Continue Its Upward Trend?

According to analyst ratings and projections for BEAM, Beam Therapeutics Inc. shares are anticipated to increase by +19.31%, potentially reaching $39.27 per share by May 6, 2026. Short-term technical indicators for BEAM currently suggest a bullish sentiment. This aligns with the stock's recent performance, as it has recorded 16 positive trading days within the past 30 sessions. Based on the BEAM stock forecast, now is a good time to buy BEAM stock because its current trading price is -16.55% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BEAM covering social and institutional perspectives.

BEAM Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BEAM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 63.88% to 75.41%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 55.89%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.64%, maintains a neutral outlook for the long term. Insights into BEAM's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Beam Therapeutics Short-Term Forecasts

BEAM Forecast For Next 5 Days

Our algorithm anticipates Beam Therapeutics (BEAM) stock could hit $27.11 by Apr 29, 2026. This represents a -14.46% fall from today's price, following a -8.09% change over the past five days.

BEAM Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Beam Therapeutics Inc. (BEAM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $27.62, which would mean a -12.84% decrease from the current price of $31.69. Projections for this period range from a high of $31.68 to a low of $22.60.

BEAM Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Beam Therapeutics's price over the next three months point to a drop. BEAM stock is expected to peak at $35.03 on May 20, 2026 before potentially dipping to $26.30 on Jul 09, 2026. On average, BEAM is likely to trade around $30.81 in the coming 90 days.

Beam Therapeutics Stock Forecast 2025

Based on our predictive models, Beam Therapeutics (BEAM) is expected to trade between $25.11 and $35.73 throughout 2026. This would result in an average price of $30.31, potentially offering investors a -4.35% return from current levels.

Beam Therapeutics Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Beam Therapeutics Inc. (BEAM) is positioned to show a strong performance in April 2026. The price is predicted to move between $28.40 and $32.77, settling at an average of $30.67. This could translate to a -3.22% loss.

May 2026

Based on current market signals, Beam Therapeutics Inc. is projected to trend may 2026. We forecast a trading range from $29.13 to $35.03, with a likely average price of $32.11. Investors could expect a potential return of +1.33%.

June 2026

Our predictive algorithms indicate Beam Therapeutics Inc. stock may see a shift in June 2026. The expected range spans $27.26–$34.38, with an average target of $30.93. This represents a cautious outlook and a possible loss of -2.40%.

July 2026

Analyzing established trends, Beam Therapeutics Inc. looks set to move in July 2026. Projections place the stock between $26.30 and $32.79, averaging around $29.46. This suggests a -7.04% loss from current levels.

August 2026

Market indicators suggest Beam Therapeutics Inc. could experience notable changes during August 2026. Prices could fluctuate within $28.37 to $34.71, with a midpoint forecast of $31.43. The stock might deliver a -0.82% loss.

September 2026

Forecasting for September 2026, models estimate that Beam Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.10 and $32.35, averaging $29.77. This signals a cautious trajectory with potential returns around -6.06%.

October 2026

According to our latest forecast models, Beam Therapeutics Inc. (BEAM) is positioned to show a strong performance in October 2026. The price is predicted to move between $27.42 and $33.72, settling at an average of $30.85. This could translate to a -2.65% loss.

November 2026

Based on current market signals, Beam Therapeutics Inc. is projected to trend november 2026. We forecast a trading range from $25.88 to $35.73, with a likely average price of $29.67. Investors could expect a potential return of -6.37%.

December 2026

Our predictive algorithms indicate Beam Therapeutics Inc. stock may see a shift in December 2026. The expected range spans $25.11–$31.62, with an average target of $28.41. This represents a cautious outlook and a possible loss of -10.35%.

January 2027

Analyzing established trends, Beam Therapeutics Inc. looks set to move in January 2027. Projections place the stock between $27.22 and $33.89, averaging around $30.23. This suggests a -4.61% loss from current levels.

February 2027

Market indicators suggest Beam Therapeutics Inc. could experience notable changes during February 2027. Prices could fluctuate within $26.18 to $30.89, with a midpoint forecast of $28.53. The stock might deliver a -9.97% loss.

March 2027

Forecasting for March 2027, models estimate that Beam Therapeutics Inc. may undergo key fluctuations. If trends hold, the stock might trade between $27.11 and $32.69, averaging $29.78. This signals a cautious trajectory with potential returns around -6.03%.

April 2027

According to our latest forecast models, Beam Therapeutics Inc. (BEAM) is positioned to show a strong performance in April 2027. The price is predicted to move between $25.17 and $32.03, settling at an average of $28.64. This could translate to a -9.62% loss.

BEAM's history of dividends and stock splits also plays a role in long-term investor confidence.